PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease.

Wells, P S; Theberge, I A; Bowdridge, J C; Forgie, M A; Carrier, M

Wells, P S; Theberge, I A; Bowdridge, J C; Forgie, M A; Carrier, M.

Afiliação

Wells PS; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Canada.
Theberge IA; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Canada.
Bowdridge JC; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Canada.
Forgie MA; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Canada.
Carrier M; Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Canada.

Thromb Res ; 140 Suppl 1: S191-2, 2016 Apr.

Article em En | MEDLINE | ID: mdl-27161729

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article